C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
12/2011
12/13/2011	CA2700045C High yielding, phytophthora resistant, cyst nematode resistant soybean variety 92y11
12/13/2011	CA2476247C Compositions for the treatment of skin conditions, disorders or diseases and methods of making and using the same
12/13/2011	CA2475821C Group b streptococcus antigens
12/13/2011	CA2410663C A cytochrome p450 enzyme associated with the synthesis of .delta. 12-epoxy groups in fatty acids of plants
12/13/2011	CA2383225C Recombinant adenoviruses preparation and adenovirus banks
12/13/2011	CA2378373C Production of rhpbgd and new therapeutic methods for treating patients with acute intermittent porphyria (aip) and other porphyric diseases
12/13/2011	CA2373071C Tapetum-specific promoters
12/13/2011	CA2358520C Soluble receptor br43x2 and methods of using
12/09/2011	CA2742467A1 Method for preparing biological tissues for use in biological prostheses
12/09/2011	CA2742464A1 Method for detoxifying a biological tissue
12/08/2011	WO2011153493A2 Biodegradable lipids for the delivery of active agents
12/08/2011	WO2011153449A1 Filamentous fungal host strains and dna constructs, and methods of use thereof
12/08/2011	WO2011153378A1 Recombinant Production of Steviol Glycosides
12/08/2011	WO2011153300A2 Monoclonal antibodies detection methods for enzymes that confer resistance to 2,4-dichlorophenoxyacetic acid in plants
12/08/2011	WO2011153236A1 Purified compositions of cardiovascular progenitor cells
12/08/2011	WO2011153205A1 Native wharton's jelly stem cells and their purification
12/08/2011	WO2011152798A1 Method for inducing pluripotency in human somatic cells with prdm14 or nfrkb
12/08/2011	WO2011152554A1 Method for producing tumor cell
12/08/2011	WO2011152524A1 Cell growth-promoting peptide and use thereof
12/08/2011	WO2011151941A1 Composition having activity of inducing proliferation or accumulation of regulatory t cell
12/08/2011	WO2011151452A1 Methods for obtaining stem cells
12/08/2011	WO2011151043A1 Process for differentiating stem cells of the amniotic membrane
12/08/2011	WO2011150690A1 Monoclonal antibody against granulocyte of chlamys farreri and preparation method thereof
12/08/2011	WO2011121158A3 Method for obtaining oligodendrocyte precursor cells
12/08/2011	WO2011097527A9 Immunoprotection of therapeutic moieties using enhanced fc regions
12/08/2011	WO2011062634A3 Monoclonal antibodies and diagnostic uses thereof
12/08/2011	US20110302674 Methods and Compositions for the Improvement of Plant Tolerance to Environmental Stresses
12/08/2011	US20110302671 Embryo sac-specific genes
12/08/2011	US20110302670 Polynucleotides and methods for the improvement of plants
12/08/2011	US20110302669 Maize variety and method of production
12/08/2011	US20110302667 Transgenic brassica event mon 88302 and methods of use thereof
12/08/2011	US20110302666 Production and use of rat spermatogonial stem cell lines
12/08/2011	US20110302665 Non-human mammals with t or b cells having predefined specificity
12/08/2011	US20110301341 Modified organs and cells for xenotransplantation
12/08/2011	US20110301339 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production
12/08/2011	US20110301338 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production
12/08/2011	US20110301337 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production
12/08/2011	US20110301332 Anti-pamp therapeutic antibodies
12/08/2011	US20110301331 Stabilized polypeptide compositions
12/08/2011	US20110301230 Gene carrier
12/08/2011	US20110301227 Proliferation-associated modulation of the splicing of the integrin alpha 6 isoforms
12/08/2011	US20110301226 Compositions and methods for treating hepatic neoplasia
12/08/2011	US20110301224 Methods and compositions for the specific inhibition of gene expression by double-stranded rna
12/08/2011	US20110301223 Compositions and methods for insecticidal control of stinkbugs
12/08/2011	US20110301218 MODIFIED snRNAs FOR USE IN THERAPY
12/08/2011	US20110301210 Use of pramipexole to treat amyotrophic lateral sclerosis
12/08/2011	US20110301160 Inhibitors of P38 and Methods of Using the Same
12/08/2011	US20110301153 Methods of treating cancer
12/08/2011	US20110301151 Dimeric iap inhibitors
12/08/2011	US20110301145 Pyridazinones, method of making, and method of use thereof
12/08/2011	US20110301108 Materials and methods for sensitizing multidrug resistant cells
12/08/2011	US20110301105 Compositions for proliferation of cells and related methods
12/08/2011	US20110301104 Transition state structure of orotate phosphoribosyl transferases and uses thereof
12/08/2011	US20110301094 New tumor suppressor gene, p28ing5
12/08/2011	US20110301093 Compositions and methods for diagnosing and treating cancer and neurodegenerative diseases related to beclin-1
12/08/2011	US20110301092 The use of a non-glycanated polypeptide for treating a cancer
12/08/2011	US20110301077 Method for production of lactoferrin
12/08/2011	US20110301073 Novel DNA-binding proteins and uses thereof
12/08/2011	US20110300632 Method of directing the evolution of an organism
12/08/2011	US20110300630 Methods for treating degenerative diseases/injuries
12/08/2011	US20110300629 TRAIL trimers, methods and uses therefor
12/08/2011	US20110300628 Enhancement of epidermal cell growth by non-protein growth factors
12/08/2011	US20110300627 Dedifferentiation and reprogramming of cells
12/08/2011	US20110300626 Electrospun Ceramic-Polymer Composite As A Scaffold for Tissue Repair
12/08/2011	US20110300625 Tissue for prosthetic implants and grafts, and methods associated therewith
12/08/2011	US20110300616 Method for creating perfusable microvessel systems
12/08/2011	US20110300603 Tagged Ligands for Enrichment of Rare Analytes from a Mixed Sample
12/08/2011	US20110300580 Selection of host cells expressing protein at high levels
12/08/2011	US20110300578 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production
12/08/2011	US20110300577 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production
12/08/2011	US20110300556 Monoclonal antibodies detection methods for enzymes that confer resistance to 2,4-dichlorophenoxyacetic acid in plants
12/08/2011	US20110300548 Gdf15 as molecular tool to monitor and enhance phenotypic stability of articular chondrocytes
12/08/2011	US20110300543 Methods for making induced pluripotent stem cells from mesenchymal stem cells
12/08/2011	US20110300263 Polypeptides having cellobiohydrolase ii activity
12/08/2011	US20110300237 Protective solutions for organs
12/08/2011	US20110300205 Self replicating rna molecules and uses thereof
12/08/2011	US20110300203 Cartilage regeneration without cell transplantation
12/08/2011	US20110300183 Method of preparing adenosine-resistant anti-tumor t lymphocytes for adoptive immunotherapy
12/08/2011	US20110300180 plant-derived vaccines against respiratory syncytial virus
12/08/2011	US20110300179 Novel Compositions and Uses Thereof
12/08/2011	US20110300172 Fusion proteins and related compositions, methods and systems for treatment and/or prevention of atherosclerosis
12/08/2011	US20110300158 Anti-serum albumin binding variants
12/08/2011	US20110300156 Human antibodies against tissue factor
12/08/2011	US20110300152 Compositions and methods for modulating cell-cell fusion via intermediate-conductance calcium-activated potassium channels
12/08/2011	US20110300144 Methods and compositions for diagnosis and treatment of cancer
12/08/2011	US20110300139 Generation, expression and characterization of the humanized k33n monoclonal antibody
12/08/2011	US20110300129 Systems and methods for enhancing vaccine efficacy
12/08/2011	US20110300128 Use of foxp2 as a marker for abnormal lymphocytes and as a target for therapy of disorders associated with abnormal lymphocytes
12/08/2011	US20110300119 Methods of enriching and using regulatory t cells
12/08/2011	US20110300115 Use of inductor agents gse24.2 for producing pharmaceutical compositions for treating illnesses relating to cellular senescence
12/08/2011	US20110300114 METHOD OF CELL CULTURE AND METHOD OF TREATMENT COMPRISING A vEPO PROTEIN VARIANT
12/08/2011	US20110300113 Death Receptor CD95 Controls Neurogenesis of Adult Neural Stem Cells in Vivo and in Vitro
12/08/2011	US20110300112 Methods for enhancing yield of stem cell cultures and enhancing stem cell therapy
12/08/2011	US20110300111 Generation of induced pluripotent stem cells without the use of viral vectors
12/08/2011	US20110300107 Compositions and Methods to Treat Cardiac Pacing Conditions
12/08/2011	US20110300103 Heterocyclic antiviral compounds
12/08/2011	US20110300099 Multi-level specific targeting of cancer cells
12/08/2011	US20110300077 Human Anti-Alpha-Synuclein Antibodies
12/08/2011	US20110300073 18f-labelled three-and four-carbon acids for pet imaging
12/08/2011	DE102010022675A1 Producing a hydrogel structure with micrometer dimensions on a substrate, comprises one channel comprising casting mold, a liquid hydrogel, freezing and removing sating mold is useful for growth of axons

1 ... 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 ... 1827